Benefits, Harms of Breast Cancer Screening Vary With Risk, Density

Share this content:
Benefits, Harms of Breast Cancer Screening Vary With Risk, Density
Benefits, Harms of Breast Cancer Screening Vary With Risk, Density

TUESDAY, Aug. 23, 2016 (HealthDay News) -- For women aged 50 years and older, benefits and harms of breast cancer screening vary with risk and breast density for all screening intervals, according to a study published online Aug. 23 in the Annals of Internal Medicine.

Using collaborative simulation modeling, Amy Trentham-Dietz, Ph.D., from the University of Wisconsin-Madison, and colleagues estimated outcomes for various screening intervals after age 50 years based on breast density and risk for breast cancer.

The researchers observed increases in screening benefits and over-diagnosis with breast density and relative risk. With increasing risk, false-positive mammograms and benign results on biopsy decreased. Breast cancer deaths averted were similar for triennial versus biennial screening among women with fatty breasts or scattered fibroglandular density and a relative risk of 1.0 or 1.3 for those aged 50 to 74 years and 65 to 74 years. For women aged 50 to 74 years at all levels of breast density and a relative risk of 4.0 and those aged 65 to 74 years with heterogeneously or extremely dense breasts and a relative risk of 4.0, breast cancer deaths averted increased with annual versus biennial screening; however, harms were elevated almost two-fold. Per quality-adjusted life-year gained, the cost was less than $100,000 with triennial screening for the average-risk subgroup and annual screening for the highest-risk subgroup.

"The results show that for all screening intervals, benefits and harms change with risk and breast density," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »